Authors/Disclosures
|
Hans H. Shuhaiber, MD
|
The institution of Dr. Shuhaiber has received research support from SPRINGWORKS . The institution of Dr. Shuhaiber has received research support from RECURSION . The institution of Dr. Shuhaiber has received research support from AstraZeneca. The institution of Dr. Shuhaiber has received research support from CTF. The institution of Dr. Shuhaiber has received research support from NFLECTION . |
|
Vasileios-Arsenios Lioutas, MD
(Beth Israel Deaconess Medical Center, Department of Neurology)
|
Dr. Lioutas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Qmetis. Dr. Lioutas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mindray. The institution of Dr. Lioutas has received research support from NIH. The institution of Dr. Lioutas has received research support from Alzheimer's Association. |
|
Eleanor Orehek, MD
(Noran Neurological Clinic)
|
No disclosure on file |
|
|
No disclosure on file |
|
Samuel A. Frank, MD, FAAN
(Beth Israel Deaconess Medical Center/Harvard Medical School)
|
Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for uniQure. Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Frank has received research support from Huntington's Disease Society of America. The institution of Dr. Frank has received research support from Roche/Genentech. The institution of Dr. Frank has received research support from CHDI Foundation. The institution of Dr. Frank has received research support from Huntington Study Group. The institution of Dr. Frank has received research support from Cerevel. |
|
David H. Miller, MD, MBChB, FRCP
(Univ Dept of Clinical Neuro)
|
No disclosure on file |